Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine Chirocaine after diagnostic hysteroscopy
ACTRN12615001214527Phase 4Recruiting
- Sponsor
- KMT
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of levobupivacaine (2 arms), sponsored by KMT. Primary endpoints: Pain score at 2 hours post-operatively, Pain in first 24 hours after surgery and 1 more. Started Sep 2014; status: recruiting.
02
Drugs
levobupivacaine
Beyond the preview
Go deeper on ACTRN12615001214527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001214527.